DNB are promoting start-ups in the Nordic healthcare sector!
This week, DNB is arranging the annual conference The DNB Nordic Healthcare Conference 2019 in Oslo. It is an opportunity for Norwegian health start-ups to connect with the investor environment and it is an important platform to promote the Nordic healthcare sector.
One of the highlights of the event is the DNB Healthcare Prize, which is awarded every year to an early-stage healthcare company within pharmaceuticals, biotech, diagnostics, medtech and eHealth.
The companies are evaluated based on their innovation capacity, business potential and an ability to execute their strategy. They also have the opportunity to present their business cases in the semi-finals.
This year, our general manager Ketil Widerberg will be the moderator for the session with the six finalists for the fifth DNB Healthcare Prize. DNB’s Trine Loe, Head of Future and Tech Industries, will announce the winner of the prize.
“Our job in Oslo Cancer Cluster is to accelerate the development of cancer treatments. By connecting investors and companies in many great projects each year, the DNB Nordic Healthcare Conference contributes to accelerating this development too.” Ketil Widerberg, General Manager, Oslo Cancer Cluster
For the first time ever, there will be a glass studio recording live interviews with CEOs, analysts and opinion makers about the healthcare sector in the Nordics during the event.
This is a collaboration between the DNB podcast “Utbytte” and the Radforsk podcast “Radium”.
They will be interviewing relevant participants during the conference and receive technical assistance from Ullern Upper Secondary students.
We are also delighted that several of our members are attending this event.
The following of our members will be presenting in Auditorium 2: Nordic Nanovector, Photocure, Ultimovacs, Targovax and PCI Biotech.
Zelluna Immunotherapy and Vaccibody are part of a separate session in Meeting room C2 on Potential IPO candidates.
Don’t miss the presentations on their exciting cancer research!